Skip to content
value.today

Graybug LLC

🇺🇸 Baltimore, Maryland, USABiotechnologyFounded 2011
Total raised
$134 M
4 rounds on record
Latest round
$55 M
Jul 2019
First round on record
Sep 2013
Today
Went public
See the company page

Graybug LLC is listed today as CalciMedica, Inc.: market value, financials and filings are on its company page.

Funding rounds

4 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Graybug LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2023$9 MPrivate placement after listing$2 to $10 million

Graybug LLC: Private sale, Mar 2023

Investors in this round

55 investors had bought by the notice of Apr 4, 2023: 55 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 17 investors are named for Graybug LLC as a whole in other filings: see Investors below.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, other: Offering of Issuer common stock and warrants to purchase shares of Issuer common stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • A. Rachel Leheny · Executive Officer, Director
  • Daniel J. Geffken · Executive Officer
  • Eric W. Roberts · Executive Officer, Director
  • Kenneth A. Stauderman · Executive Officer
  • Michael J. Dunn · Executive Officer
  • Sudarshan J. Hebbar · Executive Officer
  • Allan N. Shaw · Director
  • Eric N. Bjerkholt · Director
  • Fred N. Middleton · Director
  • Frederic N. Guerard · Director
  • Robert N. Wilson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “The Issuer issued shares and warrants as consideration for the merger of Camaro Merger Sub, Inc., its wholly-owned subsidiary, with and into CalciMedica Subsidiary, Inc.”

Signed by A. Rachel Leheny, Ph.D., Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 4, 2023. Read the notice at the SEC.

equity, optionsSEC
Jul 2019$55 MNo. 4$50 to $250 million

Graybug LLC: Raise no. 4, Jul 2019

Investors in this round

8 investors had bought by the notice of Aug 15, 2019: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 17 investors are named for Graybug LLC as a whole in other filings: see Investors below.

What the notice says

Amount sold
$55 M of $80 M offered; $25 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Frederic Guerard · Executive Officer, Director, Promoter
  • Pamela Michael Wapnick · Executive Officer, Promoter
  • Cameron Wheeler, Ph.D. · Director
  • Chau Khuong · Director
  • Christy Shaffer, Ph.D. · Director
  • Emmett Cunningham, M.D., Ph.D. · Director
  • Gerald Cagle, Ph.D. · Director
  • Hansoo Michael Keyoung · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Actual Total Offering Amount is $79,999,992.54. Actual Total Amount Sold is $54,999,993.94.”

Signed by Frederic Guerard, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 15, 2019. Read the notice at the SEC.

equitySEC
Apr 2016$75 MNo. 3$50 to $250 million

Graybug LLC: Raise no. 3, Apr 2016

Investors in this round

16 investors had bought by the notice of Jun 13, 2018: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 17 investors are named for Graybug LLC as a whole in other filings: see Investors below.

What the notice says

Amount sold
$75 M of $80 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey Cleland · Executive Officer, Director
  • Cameron Wheeler · Director
  • Chau Khoung · Director
  • Christy Shaffer · Director
  • Emmett Cunningham · Director
  • Gerald Cagle · Director
  • Justin Hanes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey L. Cleland, Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Jun 13, 2018. Read the notice at the SEC.

equitySEC
Feb 2015$2 MNo. 2Under $2 million

Graybug LLC: Raise no. 2, Feb 2015

Investors in this round

2 investors had bought by the notice of Mar 6, 2015: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 17 investors are named for Graybug LLC as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$240,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$100,000 (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael O'Rourke · Executive Officer, Director
  • Gerald Cagle · Director
  • Jeffrey Cleland · Director
  • Justin Hanes · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael O'Rourke, President and CEO. Source: SEC Form D, newest notice filed Mar 6, 2015. Read the notice at the SEC.

equity, optionsSEC
Sep 2013$1 MNo. 1Under $2 million

Graybug LLC: Raise no. 1, Sep 2013

Investors in this round

7 investors had bought by the notice of Oct 10, 2013: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 17 investors are named for Graybug LLC as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $2 M offered; $1 M still to sell
Smallest investment taken
$25,000
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
No revenue
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Maryland

People named in the notice

  • Christy Wyskiel · Executive Officer
  • Justin Hanes · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Justin Hanes, President. Source: SEC Form D and 1 amendment, newest notice filed Oct 10, 2013. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Graybug LLC chose not to state its revenue in its newest notice of a funding round (Apr 2023).

    SEC Form D · Apr 2023

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2023

That is all the official record says: Graybug LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Graybug LLC are on record.

Investors#

17 named in official filings. Open an investor to see everything it has backed.

Investors in Graybug LLC
InvestorKindAmountRoundRoleSource
Blackstone Clarus III L.L.C.Othernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Blackstone Group Management L.L.C.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Blackstone Holdings I/II GP IncCompanynot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Blackstone Holdings II L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Blackstone Inc.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Clarus Lifesciences III, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Clarus Ventures III GP, L.P.Venture capitalnot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Deerfield Healthcare Innovations Fund, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Deerfield Management Company, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Deerfield Mgmt HIF, L.PFund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Deerfield Mgmt III, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Deerfield Mgmt L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Deerfield Partners, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Deerfield Private Design Fund III, L.P.Fund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner (Form 3, 2020)SEC Form 3
Gerald D. CaglePersonnot statednot statedHeld Series B preferred stock, director (Form 3, 2020)SEC Form 3
Orbimed Advisors LLCFund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3
OrbiMed Capital GP VI LLCFund or asset managernot statednot statedHeld Series B and C preferred stock, 10% owner, director (Form 3, 2020)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 16 investors.

Largest shareholders today

Institutions holding CalciMedica, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Graybug LLC
NameRoleNamed in
A. Rachel LehenyExecutive officerApr 2023
Daniel J. GeffkenExecutive officerApr 2023
Eric W. RobertsExecutive officerApr 2023
Kenneth A. StaudermanExecutive officerApr 2023
Michael J. DunnExecutive officerApr 2023
Sudarshan J. HebbarExecutive officerApr 2023
Frederic GuerardExecutive officerAug 2019
Pamela Michael WapnickExecutive officerAug 2019
Jeffrey ClelandExecutive officerJun 2018
Jeffrey L. ClelandExecutive officerMay 2016
Michael O'RourkeExecutive officerMar 2015
Christy WyskielExecutive officerOct 2013
Justin HanesExecutive officerOct 2013
A. Rachel LehenyDirectorApr 2023
Allan N. ShawDirectorApr 2023
Eric N. BjerkholtDirectorApr 2023
Eric W. RobertsDirectorApr 2023
Fred N. MiddletonDirectorApr 2023
Frederic N. GuerardDirectorApr 2023
Robert N. WilsonDirectorApr 2023
Cameron Wheeler, Ph.D.DirectorAug 2019
Chau KhuongDirectorAug 2019
Christy Shaffer, Ph.D.DirectorAug 2019
Emmett Cunningham, M.D., Ph.D.DirectorAug 2019
Frederic GuerardDirectorAug 2019
Gerald Cagle, Ph.D.DirectorAug 2019
Hansoo Michael KeyoungDirectorAug 2019
Cameron WheelerDirectorJun 2018
Chau KhoungDirectorJun 2018
Christy ShafferDirectorJun 2018
Emmett CunninghamDirectorJun 2018
Gerald CagleDirectorJun 2018
Jeffrey ClelandDirectorJun 2018
Justin HanesDirectorJun 2018
Christy L. ShafferDirectorMay 2016
Gerald L. CagleDirectorMay 2016
Jeffrey L. ClelandDirectorMay 2016
Justin L. HanesDirectorMay 2016
Michael O'RourkeDirectorMar 2015
Frederic GuerardPromoterAug 2019

Went public since 2020. Its SEC number is that of a company listed on a stock exchange.